MYADERM

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BUCHANAN INGERSOLL & ROONEY PC	—	16

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	5
HOUSE OF REPRESENTATIVES	5
Health & Human Services, Dept of (HHS)	5
SENATE	5

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	6
Health Issues	Health Issues	6
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	6

MYADERM — Lobbying Disclosure | Poliscope